Pfizer must face lawsuit over diversity fellowship program, US court rules

A U.S. appeals court on Friday revived a lawsuit by a conservative group opposed to diversity initiatives in medicine that challenged a Pfizer (PFE.N) fellowship program designed to boost the pipeline of Black, Latino and Native American people in leadership positions at the drugmaker.

At the urging of the group Do No Harm, a 2-1 panel of the New York-based 2nd U.S. Circuit Court of Appeals revisted a decision it issued last year holding the organization lacked legal standing to challenge the drugmaker’s program in court.

Read more on Reuters.